We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the I(f)channel. Standard therapy had failed to control the tachycardia before. No side effects attributable to Ivabradine were noticed. Due to its mechanism of action Ivabradine is a promising novel agent for the therapy of tachycardia due to increased automaticity. Reports on the use of Ivabradine in young children or infants are rare, but show promising results for congenital junctional ectopic tachycardia. This report adds the second case of ectopic atrial tachycardia in this age group and novel treatment with Ivabradine to the...
Abstract Objectives: The aim of this report was to evaluate the efficacy and safety of a combined t...
Objectives.This study assessed the safety and efficacy of combined flecainide and amiodarone therapy...
BACKGROUND Heart rate reduction as a therapeutic target has been investigated in adults with heart f...
We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the co...
Supraventricular tachycardia (SVT) is a clinical condition caused by many arrhythmias and from diffe...
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic...
Background: In April 2015, ivabradine was approved by the Food and Drug Administration for the treat...
AbstractEctopic automatic atrial tachycardia, an uncommon type of supraventricular tachycardia in ch...
Congenital JET (junctional ectopic tachycardia) is a rare and often difficult to treat tachyarrhythm...
We report two cases of malignant junctional ectopic tachycardia (JET), in infants following congenit...
The incidence of multifocal atrial tachycardia (MAT) is very low and accounts for less than 1% of su...
AbstractObjectivesWe assessed the clinical presentation, natural history, and treatment response of ...
acetate for refractory symptomatic supraventricular tachycardia. Six children had direct atrioventri...
AbstractBackgroundPropranolol and digoxin have been used as first line drugs for treatment of suprav...
We present an extreme rare case of cristal atrial tachycardia (AT) in a 23-year-old male presenting ...
Abstract Objectives: The aim of this report was to evaluate the efficacy and safety of a combined t...
Objectives.This study assessed the safety and efficacy of combined flecainide and amiodarone therapy...
BACKGROUND Heart rate reduction as a therapeutic target has been investigated in adults with heart f...
We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the co...
Supraventricular tachycardia (SVT) is a clinical condition caused by many arrhythmias and from diffe...
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic...
Background: In April 2015, ivabradine was approved by the Food and Drug Administration for the treat...
AbstractEctopic automatic atrial tachycardia, an uncommon type of supraventricular tachycardia in ch...
Congenital JET (junctional ectopic tachycardia) is a rare and often difficult to treat tachyarrhythm...
We report two cases of malignant junctional ectopic tachycardia (JET), in infants following congenit...
The incidence of multifocal atrial tachycardia (MAT) is very low and accounts for less than 1% of su...
AbstractObjectivesWe assessed the clinical presentation, natural history, and treatment response of ...
acetate for refractory symptomatic supraventricular tachycardia. Six children had direct atrioventri...
AbstractBackgroundPropranolol and digoxin have been used as first line drugs for treatment of suprav...
We present an extreme rare case of cristal atrial tachycardia (AT) in a 23-year-old male presenting ...
Abstract Objectives: The aim of this report was to evaluate the efficacy and safety of a combined t...
Objectives.This study assessed the safety and efficacy of combined flecainide and amiodarone therapy...
BACKGROUND Heart rate reduction as a therapeutic target has been investigated in adults with heart f...